Otsuka Pharma Confirms Purchase of Astex Pharma at $8.50/Share in Cash


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


OtsukaPharmaceutical Co., Ltd. ("Otsuka") and Astex Pharmaceuticals, Inc.(Nasdaq: ASTX) ("Astex"), announced today that their respective Boards ofDirectors have unanimously approved a transaction under which Otsuka willacquire all of the outstanding shares of Astex for $8.50 per share in cashrepresenting a 48% premium to the average closing stock price for the prior 30day period. The purchase price represents a fully diluted equity value ofapproximately $886 million, calculated using the treasury stock method. Otsukaintends to effect the transaction through a tender offer and expects to closethe transaction early in the fourth quarter of 2013, subject to thesatisfaction of customary closing conditions.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsM&A